CLARITY Act faces trafficking backlash over DeFi liability rules
The CLARITY Act is facing new opposition ahead of a potential Senate vote. The Alliance to End Human Trafficking (AEHT) urged Senate leaders John Thune and Chuck Schumer to revisit Section 604, which would tie the Blockchain Regulatory Certainty Act (BRCA) to DeFi.
AEHT’s core claim is that the CLARITY Act’s DeFi provision could weaken safeguards against illicit finance. Section 604 would protect software developers building decentralized blockchain applications from user-committed crimes and would exempt them from being treated as money transmitters. AEHT argues this could create regulatory gaps that make it harder for authorities to track and detect financial activity connected to human trafficking.
Lawmakers are also navigating other politically sensitive items, including ethics rules and language affecting prediction markets. The Senate has a narrowing window before its August recess, while the U.S. House has scheduled a hearing for July 17. Recent estimates suggest 80%–85% of the CLARITY Act may be finalized, but unresolved provisions—especially around BRCA and ethics—remain.
Supporters are still lobbying. The Digital Chamber said it met legislators (including Sen. Cynthia Lummis) to push for a clearer market-structure framework. Market sentiment appears cautious: Polymarket assigns 42% odds that President Trump signs the CLARITY Act before end-2026.
Key takeaway for traders: the CLARITY Act’s timeline and DeFi compliance details remain uncertain, which can sustain regulatory-risk volatility across crypto-related assets.
Bearish
This is mildly bearish because the CLARITY Act’s DeFi liability framework is being challenged by an anti-trafficking group, raising the risk of further amendments or delays. Historically, when US crypto bills face late-stage compliance or enforcement concerns, markets often price in regulatory uncertainty first—leading to risk-off positioning and wider spreads—before clearer language emerges.
In the short term, traders may see more volatility around any Senate signaling, especially because Polymarket’s 42% signing odds suggest the outcome is far from assured. The focus on Section 604/BRCA also matters for DeFi tokens and builders: if legislators narrow developer protections or add AML/accountability requirements, sentiment can deteriorate.
In the long term, if the bill ultimately passes with stronger AML and accountability measures, the result could become sentiment-neutral to eventually positive for market structure. But for now, the combination of unresolved ethics/BRCA details, lobbying pressure, and a narrowing legislative calendar increases downside risk.